Ligand Pharmaceuticals Inc (NASDAQ:LGND) has 338 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 2,961,923 | 21,692 | 0.74% | $591,347,927.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 2,940,231 | 55,704 | 1.93% | $555,909,475.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 2,073,892 | -2,391 | -0.12% | $392,110,761.00 |
| Janus Henderson Group Plc | 31 Mar, 2026 | 2,019,782 | 1,024,382 | 102.91% | $403,245,874.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 1,100,267 | 1,100,267 | 0.00% | $219,668,307.00 |
| Janus Henderson Group Plc | 31 Mar, 2026 | 995,400 | -46,978 | -4.51% | $188,199,064.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 858,008 | 490,213 | 133.28% | $162,223,572.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 848,089 | 848,089 | 0.00% | $169,320,969.00 |
| Invesco Ltd. | 31 Mar, 2026 | 823,604 | 307,140 | 59.47% | $164,432,539.00 |
| State Street Corp | 31 Mar, 2026 | 778,856 | 27,651 | 3.68% | $155,498,600.00 |
| State Street Corp | 31 Mar, 2026 | 751,205 | 1,845 | 0.25% | $142,030,329.00 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 31 Mar, 2026 | 644,093 | 644,093 | 0.00% | $121,779,000.00 |
| FMR LLC | 31 Mar, 2026 | 596,127 | 16,972 | 2.93% | $119,016,815.00 |
| FMR LLC | 31 Mar, 2026 | 579,155 | 121,924 | 26.67% | $109,500,870.00 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 31 Mar, 2026 | 573,312 | -70,781 | -10.99% | $114,462,000.00 |
| Franklin Resources Inc | 31 Mar, 2026 | 573,177 | 77,017 | 15.52% | $114,434,772.00 |
| Chicago Capital, LLC | 31 Mar, 2026 | 561,423 | -7,188 | -1.26% | $106,148,307.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 558,934 | 65,345 | 13.24% | $111,608,727.00 |
| Invesco Ltd. | 31 Mar, 2026 | 516,464 | 138,169 | 36.52% | $97,647,849.00 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 31 Mar, 2026 | 507,019 | -34,826 | -6.43% | $95,862,082.00 |